SOLU-MEDROL® How Supplied/Storage and Handling (methylprednisolone sodium succinate)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

HOW SUPPLIED

SOLU-MEDROL Sterile Powder preserved with benzyl alcohol is available in the following packages:

500 mg (Multi-Dose Vial)
8 mL NDC 0009-0758-01
2 gram Vial (Single-Dose Vial)
NDC 0009-0850-01

1 gram (Multi-Dose Vial)
16 mL NDC 0009-0698-01
2 gram Vial with Diluent (Single-Dose Vial)
NDC 0009-0796-01

SOLU-MEDROL Sterile Powder preservative-free is available in the following packages:

40 mg Act-O-Vial System (Single-Dose Vial)
  25 ×1 mL NDC 0009-0039-28
125 mg Act-O-Vial System (Single-Dose Vial)
  25 × 2 mL NDC 0009-0047-22
500 mg Act-O-Vial System (Single-Dose Vial)
  4 mL NDC 0009-0003-02

1 gram Act-O-Vial System (Single-Dose Vial)
8 mL NDC 0009-0018-20

This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.

STORAGE CONDITIONS

Protect from light.

Store unreconstituted product at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].

Store reconstituted solution (not further diluted) at controlled room temperature 20° to 25°C (68° to 77°F) [see USP], and use it within 48 hours.

See section DOSAGE AND ADMINISTRATION, for storage of further diluted solution.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

SOLU-MEDROL® Quick Finder

Ingredient & Allergen Checker
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the ...